5-Bromo-2,4-Dichloropyrimidines CAS 36082-50-5 Puritas >99.0% (GC) Palbociclib Factory intermedia Featured Image

5-Bromo-2,4-Dichloropyrimidines CAS 36082-50-5 Puritas >99.0% (GC) Palbociclib Factory intermedium

Description:

Nomen chemicum: 5-Bromo-2,4-Dichloropyrimidine

CAS: 36082-50-5

Puritas: >99.0% (GC)

Aspectus: hyalina ad lux Yellow Liquid

Medium Palbociclib (CAS: 571190-30-2)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Mitte ad nos inscriptio

Product Detail

Product Tags

Descriptio:

Ruifu Chemical Supple Palbociclib Intermedia:
Palbociclib CAS 571190-30-2
5-Bromo-2,4-Dichloropyrimidines CAS 36082-50-5
5-Bromo-2-Chloro-N-Cyclopentylpyrimidin-4-Amine CAS 733039-20-8
tert-Butyl 4-(6-Nitropyridin-3-yl) piperazine-1-Carboxylate CAS 571189-16-7
tert-Butyl 4-(6-Amino-3-pyridyl) piperazine-1-Carboxylate CAS 571188-59-5
6-Bromo-2-Chloro-8-Cyclopentyl-5-Methylpyrido-[2,3-d]pyrimidin-7(8H)-one CAS 1016636-76-2
2-Chloro-8-Cyclopentyl-5-Methyl-8H-pyrido[2,3-d]pyrimidin-7-one CAS 1013916-37-4

Chemical Properties:

Nomen chemicum	5-Bromo-2,4-Dichloropyrimidine
CAS Number	36082-50-5
CATTUS Number	RF-PI1852
Stock Status	In Stock, Productio Ascendite ad Tons
Formulae hypotheticae	C4HBrCl2N2
M. Pondus	227.87
Ferveret	128℃/15 mmHg (lit.)
Density	1.781 g/mL ad 25℃ (lit.)
Index refractivus	n20/D 1.603 (lit.)
Solubilitas	Solutum in Methanol
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Aspectus	Hyalina lux Yellow Liquid
Puritas / Analysis Methodus	>99.0% (GC)
Liquescens punctum	29.0~30.0℃
Aqua (auctore Karl Fischer)	<0.50%
2,4-Dichloropyrimidine	<0.50% (GC)
Maximun Single Impurity	<0.50% (GC)
Totalis immunditias	<1.00%
1 H NMR Spectrum	Congruunt cum Structure
Test Standard	Enterprise Standard
Consuetudinem	Medium Palbociclib (CAS: 571190-30-2)

Sarcina & Repono:

sarcina: Fluorinated Utrem, 25kg/Drum, vel secundum exigentiam mos

Repono Condition:Repone in vasis signatis in loco frigido et sicco;Protege a lumine et humore

commoda:

FAQ:

Applicatio:

5-Bromo-2,4-Dichloropyrimidines (CAS: 36082-50-5) adhiberi potest ut primum reagens synthesin modulatorum allostericorum positivorum pro receptoribus GABAB (medicamento similium compositorum) et analogorum pyridinepyrimidinorum.5-Bromo-2,4-Dichloropyrimidine uti potest ut intermedius Palbociclib (CAS: 571190-30-2).Palbociclib (quoque notus numerus compositorum PD-0332991) experimentale medicamentum est ad curationem cancri pectoris a Pfizer crescendo.Palbociclib inhibitor selectivorum cyclini-dependens kinases CDK4 et CDK6 est.